Cosentyx (secukinumab) met the primary endpoints of superiority compared to placebo in patients with difficult-to-treat psoriasis of the nails, palms…
16-8-2013 — /EuropaWire/ — Immunologists at LMU have come up with a new technique that can be used both to fight…